EWEdwards Lifesciences
Edwards Lifesciences Corporation is the leading global structural heart innovation company, driven by a passion to improve patient lives. 10-K, Item 1
- Employees
- 16,000
- Headquarters
- Irvine, CA
- CEO
- Bernard J. Zovighian
- Next results
- around Feb 9, 2027
Every trade in EW shares that directors, officers and 10% owners reported on Form 4 since May 14, 2026. Open-market buys and sales are the trades the insider chose to make; grants, option exercises and shares withheld for tax are part of pay.
| Date | Insider | Role | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Donald E. Bobo Jr | CVP,Strategy/Corp Development | Sale (10b5-1) | -48,900 | 103.05 | 5.0M | 22,798 |
| Nov 9, 2026 | Bernard J. Zovighian | CEO, Director | Sale (10b5-1) | -9,184 | 103.39 | 949K | 112,761 |
| Nov 9, 2026 | Bernard J. Zovighian | CEO, Director | Sale (10b5-1) | -13,916 | 102.78 | 1.4M | 98,845 |
| Oct 8, 2026 | Daniel J. Lippis | CVP, TAVR | Sale (10b5-1) | -619 | 85.65 | 53K | 40,034 |
| Sep 11, 2026 | Daniel J. Lippis | CVP, TAVR | Sale (10b5-1) | -619 | 87.51 | 54K | 40,034 |
| Aug 31, 2026 | Andrew M. Dahl | SVP, Corporate Controller | Sale | -544 | 91.06 | 50K | 14,868 |
| Aug 28, 2026 | Annette Bruls | CVP, EMEACLA | Sale | -2,644 | 89.98 | 238K | 17,984 |
| Aug 26, 2026 | Wayne Markowitz | CVP, JAPAC | Sale | -1,240 | 91.47 | 113K | 20,294 |
| Aug 26, 2026 | Daveen Chopra | CVP, TMTT, Surgical & IHFM | Sale | -1,154 | 91.76 | 106K | 74,970 |
| Aug 26, 2026 | Daveen Chopra | CVP, TMTT, Surgical & IHFM | Sale | -30,646 | 90.99 | 2.8M | 44,324 |
| Aug 11, 2026 | Daniel J. Lippis | CVP, TAVR | Sale (10b5-1) | -619 | 92.03 | 57K | 40,034 |
| Jul 30, 2026 | Wayne Markowitz | CVP, JAPAC | Sale | -146 | 86.03 | 13K | 21,534 |
| Jul 28, 2026 | Wayne Markowitz | CVP, JAPAC | Sale | -9,628 | 85.06 | 819K | 21,680 |
| Jul 27, 2026 | Bernard J. Zovighian (indirect) | CEO, Director | Sale | -2,921 | 83.93 | 245K | 8,916 |
| Jul 10, 2026 | Daniel J. Lippis | CVP, TAVR | Sale (10b5-1) | -619 | 91.70 | 57K | 40,034 |
| Jun 30, 2026 | Daniel J. Lippis | CVP, TAVR | Sale (10b5-1) | -619 | 91.40 | 57K | 40,411 |
| Jun 17, 2026 | Bernard J. Zovighian (indirect) | CEO, Director | Sale (10b5-1) | -523 | 87.92 | 46K | 11,517 |
| May 29, 2026 | Andrew M. Dahl | SVP, Corporate Controller | Sale | -568 | 86.08 | 49K | 15,334 |
| May 27, 2026 | Donald E. Bobo Jr (indirect) | CVP,Strategy/Corp Development | Sale | -23,145 | 86.42 | 2.0M | 98,611 |
| May 22, 2026 | Daveen Chopra | CVP, TMTT & Surgical | Sale | -1,500 | 84.60 | 127K | 44,324 |
| May 18, 2026 | Daniel J. Lippis | CVP, TAVR | Sale (10b5-1) | -620 | 81.14 | 50K | 40,411 |
| May 15, 2026 | Donald E. Bobo Jr | CVP,Strategy/Corp Development | Sale | -9,968 | 82.07 | 818K | 22,798 |
| May 15, 2026 | Donald E. Bobo Jr (indirect) | CVP,Strategy/Corp Development | Sale | -8,000 | 81.82 | 655K | 30,970 |
From the Form 4s in SEC's filing index; each date links to the filing. The Insider selling plans tab shows planned sales (10b5-1 plans and Form 144).
Work on EW in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/EW/export.csv") into a cell.